SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001174947-19-000010
Filing Date
2019-01-08
Accepted
2019-01-07 18:58:58
Documents
4
Period of Report
2019-02-02
Effectiveness Date
2019-01-08

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT tv510447-def14a.htm DEF 14A 293464
2 GRAPHIC lg_georgeson.jpg GRAPHIC 23002
3 GRAPHIC tv510447_pc-pg01.jpg GRAPHIC 275644
4 GRAPHIC tv510447_pc-pg02.jpg GRAPHIC 180062
  Complete submission text file 0001174947-19-000010.txt   933962
Mailing Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814
Business Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814 (240) 497-9024
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

IRS No.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35737 | Film No.: 19514340
SIC: 2834 Pharmaceutical Preparations